{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:39:12Z","timestamp":1789925952091,"version":"4.0.1"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Shanghai Committee of Science and Technology, China","award":["17411970900"],"award-info":[{"award-number":["17411970900"]}]},{"name":"Shanghai Committee of Science and Technology, China","award":["18411950400"],"award-info":[{"award-number":["18411950400"]}]},{"name":"The\u2002State\u2002Key\u2002Program\u2002of\u2002National\u2002Natural\u2002Science\u2002of\u2002China","award":["81830010"],"award-info":[{"award-number":["81830010"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Pulmonary vein stenosis (PVS) after radiofrequency ablation for non-valvular atrial fibrillation (AF) is an uncommon but serious complication. PVS stenting can rapidly restore pulmonary flow and improve symptoms with long-term low incidence of restenosis. However, high risk of thrombosis remains if AF is recurrent, especially for CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc &gt;\u20092.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 67-year-old man with diabetes, hypertension and a history of stroke underwent radiofrequency pulmonary vein isolation for persistent AF 1 year ago. Six months later he developed recurrent respiratory infection and massive hemoptysis. Computed tomography pulmonary angiography revealed severe left pulmonary vein stenosis. Simultaneous percutaneous PVS stenting and left atrial appendage occlusion were performed to resolve recurrent hemoptysis and prevent stroke. The clinical follow-up indicated a good short and mid-term result with significant improvement of symptoms.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Simultaneous PVS stenting and left atrial appendage occlusion is feasible and effective in patients with recurrence of AF and hemoptysis induced by radiofrequency ablation for AF.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12872-020-01483-4","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T17:02:39Z","timestamp":1587574959000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Combined pulmonary vein stenosis stenting and left atrial appendage occlusion in a patient with hemoptysis after atrial fibrillation ablation"],"prefix":"10.1186","volume":"20","author":[{"given":"Yan-Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"issue":"1","key":"1483_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12872-019-1141-0","volume":"19","author":"D Yu","year":"2019","unstructured":"Yu D, Jie B, Li LL, Jiang S. Bilateral pulmonary vein stenting for treatment of massive hemoptysis caused by pulmonary vein stenosis following catheter ablation for atrial fibrillation. BMC Cardiovasc Disord. 2019;19(1):162.","journal-title":"BMC Cardiovasc Disord"},{"key":"1483_CR2","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijcard.2019.11.147","volume":"301","author":"YJ Li","year":"2020","unstructured":"Li YJ, Pan X, Wang C, He B. Stent implantation for severe pulmonary vein stenosis or occlusion secondary to atrial fibrillation ablation. Int J Cardiol. 2020;301:85\u20139.","journal-title":"Int J Cardiol"},{"issue":"16","key":"1483_CR3","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.jcin.2018.05.020","volume":"11","author":"EA Fender","year":"2018","unstructured":"Fender EA, Widmer RJ, Hodge DO, Packer DL, Holmes DR Jr. Assessment and management of pulmonary vein occlusion after atrial fibrillation ablation. JACC Cardiovasc Interv. 2018;11(16):1633\u20139.","journal-title":"JACC Cardiovasc Interv"},{"issue":"13","key":"1483_CR4","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.4244\/EIJY19M08_01","volume":"15","author":"M Glikson","year":"2020","unstructured":"Glikson M, Wolff R, Hindricks G, Mandrola J, Camm AJ, Lip GYH, et al. EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. EuroIntervention. 2020;15(13):1133\u201380.","journal-title":"EuroIntervention."},{"issue":"1","key":"1483_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12872-018-0899-9","volume":"18","author":"C Fastner","year":"2018","unstructured":"Fastner C, Hoffmann L, Aboukoura M, Behnes M, Lang S, Borggrefe M, et al. Real-world experience comparing two common left atrial appendage closure devices. BMC Cardiovasc Disord. 2018;18(1):171.","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"1483_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.118.006461","volume":"11","author":"SK Padala","year":"2018","unstructured":"Padala SK, Ellenbogen KA. Pulmonary vein stenosis after atrial fibrillation ablation: an iatrogenic problem larger than the primary problem. Circ Arrhythm Electrophysiol. 2018;11(5):e006461.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"5","key":"1483_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.117.006001","volume":"11","author":"P Raeisi-Giglou","year":"2018","unstructured":"Raeisi-Giglou P, Wazni OM, Saliba WI, Barakat A, Tarakji KG, Rickard J, et al. Outcomes and management of patients with severe pulmonary vein stenosis from prior atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2018;11(5):e006001.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"24","key":"1483_CR8","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","volume":"70","author":"VY Reddy","year":"2017","unstructured":"Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017;70(24):2964\u201375.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"1483_CR9","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.jacc.2016.02.053","volume":"67","author":"D Sharma","year":"2016","unstructured":"Sharma D, Reddy VY, Sandri M, Schulz P, Majunke N, Hala P, et al. Left atrial appendage closure in patients with contraindications to oral anticoagulation. J Am Coll Cardiol. 2016;67(18):2190\u20132.","journal-title":"J Am Coll Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01483-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-020-01483-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-020-01483-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T23:31:12Z","timestamp":1619047872000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-020-01483-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1483"],"URL":"https:\/\/doi.org\/10.1186\/s12872-020-01483-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]},"assertion":[{"value":"13 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the study participant.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors declare no potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"191"}}